Replies to post #64628 on SOHM Inc (SHMN)

[hardlesson]

Same story with most OTC stocks. Verify/Investigate, before trusting. SHMN is no different, and it will be that way because they have had so many prior swings and misses. Nothing wrong with caution. My viewpoint is different at the moment, with Aguilar, Rushing, Bhat, and others. Aguilar and Rushing have long and verifiable backgrounds in Pharma and FDA.

I'm withholding judgement on them until they have adequate time to prove themselves. Proof will be in sales over time, reflected in filings.

We've seen pictures of our management, and videos of Facilities, in San Diego and Arizona. Proof of activity.

We have verifiable proof from the FDA site that they have registered San Diego and Carlsbad.

We need patience and should expect some delays. We can't expect to snap our fingers and get results.

They know they are accountable. Let's see if they deliver.

hL shmn imo.

[Myth]

what's amazing about shareholders checking out the new facility MP ?

They gave us the address, we're just doing what any interested shareholder would do...

Seems like we're always investigating to see if they actually do what they say they're doing.

sell and move on, buy some Microsoft..

I don't think if Microsoft said they were expanding or adding a new mfg facility we would think twice

worry about what you say you're doing..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173492823

[SLC-JD]

Seriously? You're comparing SHMN with MSFT? $.0013 to $375?

Yes, there is some (well earned) distrust with SHMN's announcements, and they need to prove to the market that they're not blowing smoke. In the meantime, investors will want to do some enhanced diligence.

I suspect that there may have been more than a few investors who were actively following up with Microsoft's claims when they were trading at <$1 back in the 80s.

[drugmanrx]

Night has lost a lot of credibility over the last 3 years.

Mainly because he put out all those PR's and NEVER followed though.

Add in the lack of any significant change in revenue during that same period and you have a Missouri situation (Don't tell me show me)

Lucky for shareholders over the last 6 months there are things that can be seen.
- locations registered with the FDA
- new product listed with the FDA
- modernized website
- acquisition of ABBIE

The only thing left IS TO SHOW they can generate revenue then the stock price will take care of itself.